Allianz Asset Management GmbH Has $3.64 Million Stock Position in Cabot Corporation $CBT

Allianz Asset Management GmbH lowered its stake in Cabot Corporation (NYSE:CBT) by 24.2% in the third quarter, Holdings Channel reports. The fund owned 47,894 shares of the specialty chemicals company’s stock after selling 15,301 shares during the quarter. Allianz Asset Management GmbH’s holdings in Cabot were worth $3,642,000 at the end of the most recent reporting period.

Other hedge funds have also recently made changes to their positions in the company. Elevation Point Wealth Partners LLC acquired a new stake in Cabot during the 2nd quarter worth approximately $28,000. Parkside Financial Bank & Trust lifted its stake in Cabot by 95.5% in the second quarter. Parkside Financial Bank & Trust now owns 387 shares of the specialty chemicals company’s stock valued at $29,000 after buying an additional 189 shares during the period. Geneos Wealth Management Inc. boosted its stake in Cabot by 409.0% during the first quarter. Geneos Wealth Management Inc. now owns 453 shares of the specialty chemicals company’s stock worth $38,000 after acquiring an additional 364 shares in the last quarter. Bayforest Capital Ltd bought a new position in shares of Cabot during the 3rd quarter worth about $46,000. Finally, EverSource Wealth Advisors LLC grew its stake in Cabot by 344.3% in the second quarter. EverSource Wealth Advisors LLC now owns 813 shares of the specialty chemicals company’s stock valued at $61,000 after acquiring an additional 630 shares during the period. 93.18% of the stock is owned by institutional investors and hedge funds.

Cabot Stock Up 1.5%

Shares of NYSE:CBT opened at $75.73 on Wednesday. The company has a market cap of $3.95 billion, a price-to-earnings ratio of 13.26, a PEG ratio of 3.91 and a beta of 0.88. Cabot Corporation has a one year low of $58.33 and a one year high of $89.15. The firm has a fifty day moving average price of $69.74 and a two-hundred day moving average price of $71.60. The company has a debt-to-equity ratio of 0.49, a current ratio of 1.67 and a quick ratio of 1.09.

Cabot (NYSE:CBT) last posted its quarterly earnings data on Tuesday, February 3rd. The specialty chemicals company reported $1.53 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.40 by $0.13. The company had revenue of $849.00 million during the quarter, compared to analyst estimates of $889.11 million. Cabot had a return on equity of 22.82% and a net margin of 8.62%.The firm’s quarterly revenue was down 11.1% on a year-over-year basis. During the same quarter last year, the company earned $1.76 earnings per share. Cabot has set its FY 2026 guidance at 6.000-6.500 EPS. Analysts anticipate that Cabot Corporation will post 7.57 EPS for the current fiscal year.

Cabot Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, March 13th. Investors of record on Friday, February 27th will be paid a $0.45 dividend. This represents a $1.80 dividend on an annualized basis and a yield of 2.4%. The ex-dividend date of this dividend is Friday, February 27th. Cabot’s dividend payout ratio (DPR) is currently 31.52%.

Wall Street Analyst Weigh In

Several brokerages have recently commented on CBT. Weiss Ratings reissued a “hold (c-)” rating on shares of Cabot in a research note on Monday, December 29th. Jefferies Financial Group reissued a “buy” rating and issued a $85.00 target price on shares of Cabot in a research report on Wednesday, February 4th. Zacks Research raised Cabot from a “strong sell” rating to a “hold” rating in a research report on Tuesday, January 27th. UBS Group boosted their price objective on Cabot from $74.00 to $81.00 and gave the company a “neutral” rating in a research note on Thursday, February 5th. Finally, JPMorgan Chase & Co. reduced their target price on shares of Cabot from $75.00 to $54.00 and set an “underweight” rating for the company in a research note on Friday, November 28th. One analyst has rated the stock with a Buy rating, four have assigned a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and a consensus price target of $73.75.

Cabot Company Profile

Cabot Corporation is a global specialty chemicals and performance materials company headquartered in Boston, Massachusetts. Founded in 1882 by Godfrey Lowell Cabot, the company has grown into a diversified manufacturer with operations across North America, Europe, Asia and Latin America. Cabot serves a wide range of end markets, including automotive, industrial, energy, and consumer products, supplying essential ingredients that enhance performance, durability and functionality.

The company operates two primary segments: Reinforcement Materials and Performance Materials.